DE60116860D1 - Zusammensetzungen zur behandlung von schäden verursacht durch ischämie / reperfusion oder oxidativem stress - Google Patents

Zusammensetzungen zur behandlung von schäden verursacht durch ischämie / reperfusion oder oxidativem stress

Info

Publication number
DE60116860D1
DE60116860D1 DE60116860T DE60116860T DE60116860D1 DE 60116860 D1 DE60116860 D1 DE 60116860D1 DE 60116860 T DE60116860 T DE 60116860T DE 60116860 T DE60116860 T DE 60116860T DE 60116860 D1 DE60116860 D1 DE 60116860D1
Authority
DE
Germany
Prior art keywords
reperfusion
ischemia
oxidative stress
damage caused
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60116860T
Other languages
English (en)
Other versions
DE60116860T2 (de
Inventor
Norren Klaske Van
Hoorn Christiaan Van
Gerrit Leuvenink
Zandrie Hofman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of DE60116860D1 publication Critical patent/DE60116860D1/de
Application granted granted Critical
Publication of DE60116860T2 publication Critical patent/DE60116860T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heat Treatment Of Articles (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
  • Processing Of Meat And Fish (AREA)
  • Medicinal Preparation (AREA)
DE60116860T 2000-03-22 2001-03-22 Zusammensetzungen zur behandlung von schäden verursacht durch ischämie / reperfusion oder oxidativem stress Expired - Lifetime DE60116860T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00201051A EP1136073A1 (de) 2000-03-22 2000-03-22 Zusammensetzungen zur Behandlung von Schäden verursacht durch Ischämie/Reperfusion oder oxidativem Stress
NL0201051 2000-03-22
PCT/NL2001/000233 WO2001070248A1 (en) 2000-03-22 2001-03-22 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress

Publications (2)

Publication Number Publication Date
DE60116860D1 true DE60116860D1 (de) 2006-04-13
DE60116860T2 DE60116860T2 (de) 2006-09-21

Family

ID=8171244

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60116860T Expired - Lifetime DE60116860T2 (de) 2000-03-22 2001-03-22 Zusammensetzungen zur behandlung von schäden verursacht durch ischämie / reperfusion oder oxidativem stress

Country Status (10)

Country Link
US (2) US20040076692A1 (de)
EP (2) EP1136073A1 (de)
JP (1) JP2003527434A (de)
AT (1) ATE316382T1 (de)
AU (1) AU2001242876A1 (de)
DE (1) DE60116860T2 (de)
DK (1) DK1267901T3 (de)
ES (1) ES2257401T3 (de)
HK (1) HK1051503A1 (de)
WO (1) WO2001070248A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939115B2 (en) * 2000-06-12 2011-05-10 Access Business Group International Llc Dietary supplement and related method
US7438936B2 (en) * 2000-06-12 2008-10-21 Access Business Group International Llc Dietary supplement and related method
US7416749B2 (en) * 2000-06-12 2008-08-26 Access Business Group International Llc Dietary supplement and related method
WO2003041703A2 (en) * 2001-11-16 2003-05-22 Gho Holding B.V. Use of a flavonoid for the treatment of burns
US20060293256A1 (en) * 2002-08-06 2006-12-28 Masateru Yamada Remedy or preventive for kidney disease and method of diagnosing kidney disease
DE10257360A1 (de) * 2002-12-09 2004-07-08 Fresenius Kabi Deutschland Gmbh Gastro-intestinal verabreichbare Formulierung und deren Verwendung
FR2854307A1 (fr) * 2003-04-30 2004-11-05 Jean Morelle Utilisation de complements vegetaux d'origine alimentaire, de proprietes anti-stress oxydatif dans le cadre de l'effort physique, humain ou animal
JP2005097222A (ja) * 2003-08-26 2005-04-14 Toyo Shinyaku:Kk タマネギ発酵物
CA2539485A1 (en) * 2003-09-19 2005-03-31 N.V. Nutricia Method and composition for preventing multiple organ dysfunction syndrome
JP4571952B2 (ja) 2004-02-05 2010-10-27 アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー 抗アレルギー組成物及び関連方法
JP2008506785A (ja) 2004-07-21 2008-03-06 フロリダ大学 リサーチファウンデーション インコーポレイティッド インスリン抵抗性の治療及び予防のための組成物及び方法
AU2006222556B2 (en) * 2005-03-11 2011-09-29 Armaron Bio Pty Ltd Flavonoid compounds and uses thereof
CA2617161A1 (en) * 2005-07-21 2007-02-15 University Of Florida Research Foundation, Inc. Compositions and methods for treatment and prevention of hyperuricemia related health consequences
EP2251024A4 (de) * 2008-01-23 2011-12-28 Kaneka Corp Arzneimittel pflanzlichen ursprungs zur prävention oder besserung von hyperurikämie
US8648059B2 (en) * 2008-03-13 2014-02-11 The Regents Of The University Of California Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling
CN102872127B (zh) * 2012-10-27 2013-07-17 吴俊华 Houttuynoid C在预防或治疗胰腺纤维化的药物中的应用
CN102872124B (zh) * 2012-10-27 2013-10-23 南京大学 Houttuynoid A在预防或治疗胰腺纤维化的药物中的应用
JP7401863B2 (ja) * 2020-10-08 2023-12-20 国立大学法人 鹿児島大学 血管攣縮抑制剤、血管攣縮予防剤、血管攣縮予防用経口組成物及び血管攣縮抑制用経口組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2903318B2 (ja) * 1989-04-04 1999-06-07 日研フード株式会社 抗酸化的ストレス物
FR2697159B1 (fr) * 1992-10-22 1995-01-13 Oreal Composition cosmétique ou dermo-pharmaceutique contenant en association un lauroylméthionate d'un amino acide basique et au moins un polyphénol.
FR2699818B1 (fr) * 1992-12-24 1995-02-03 Oreal Composition cosmétique ou pharmaceutique contenant en association un polyphénol et un extrait de gingko.
GB2290487B (en) * 1994-06-23 1998-06-10 John Hunter Dual fuel fluidised bed gasification-combustion system
DE4441279C1 (de) * 1994-11-19 1995-09-21 Abb Management Ag Vorrichtung zur Strombegrenzung
IT1286564B1 (it) * 1996-03-05 1998-07-15 Comiter Trading & Services S R Un prodotto a base di olio extravergine di oliva,olio vergine di oliva od olio di oliva arricchito ed integrato,ed un procedimento per
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US5886029A (en) * 1997-09-05 1999-03-23 Dhaliwal; Kirpal S. Method and composition for treatment of diabetes
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
WO2000007578A2 (de) * 1998-08-06 2000-02-17 Vascular Biotech Gmbh Wirkstoffkombination insbesondere zur prophylaxe und therapie von ischämischen organschäden und reperfusionssyndromen
EP1124561B1 (de) * 1998-10-29 2004-07-21 MERCK PATENT GmbH Zusammensetzung enthaltend eine mischung von bioflavonoiden
DE29908634U1 (de) * 1999-04-09 1999-12-16 Hoensch Harald Nahrungsergänzungsmittel zur Behandlung von Darmerkrankungen
EP1173069A1 (de) * 1999-04-26 2002-01-23 Imperial Sensus, L.L.C. Granuliertes verabreichungssystem
US6291533B1 (en) * 1999-12-22 2001-09-18 Vitamerica, Inc. Dietary supplements for each specific blood type

Also Published As

Publication number Publication date
EP1267901B1 (de) 2006-01-25
EP1136073A1 (de) 2001-09-26
ES2257401T3 (es) 2006-08-01
US20060270615A1 (en) 2006-11-30
EP1267901B9 (de) 2006-06-28
HK1051503A1 (en) 2003-08-08
DK1267901T3 (da) 2006-05-29
DE60116860T2 (de) 2006-09-21
WO2001070248A1 (en) 2001-09-27
ATE316382T1 (de) 2006-02-15
EP1267901A1 (de) 2003-01-02
AU2001242876A1 (en) 2001-10-03
US20040076692A1 (en) 2004-04-22
JP2003527434A (ja) 2003-09-16

Similar Documents

Publication Publication Date Title
ATE316382T1 (de) Zusammensetzungen zur behandlung von schäden verursacht durch ischämie / reperfusion oder oxidativem stress
MX9304638A (es) Composicion para tratar e inhibir las ulceras gastricas y duodenales.
ATE207342T1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
IL143332A0 (en) Scavenger compounds
BR0212374A (pt) Oxintomodulina para a prevenção ou para o tratamento do excesso de peso
DE69729946D1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
BR0115427A (pt) Composto, composição farmacêutica, métodos para inibir a liberação de peptìdeo beta-amilóide e/ou sua sìntese, para tratar a doença de alzheimer, e para prevenir a doença e o progresso da doença de alzheimer, e, uso de um composto
ATE188341T1 (de) Konservierungsmittel und verfahren zur behandlung von holz
DE69531753D1 (de) Verbindungen zur Hemmung der Thrombin
EE9700200A (et) Bis-aminohappe hüdroksüetüülamino-sulfoonamiidsed retroviirusliku proteaasi inhibiitorid
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
DE69911935D1 (de) Granulatimide-derivate zur behandlung von krebs
DE60335647D1 (de) Pyrroloquinoline quinone und ein betablocker zur behandlung von ischämie oder reperfusionsschäden
DE69927584D1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
TR200101568T2 (tr) Sülfonamid bileşimleri ve bunların ilaç olarak kullanımları
ATE273011T1 (de) Zusammensetzung und verfahren zur behandlung von herpes simplex
DE69113162D1 (de) Antiallergische Mischung.
ATE332697T1 (de) Cyanidinmischung zur behandlung von dickdarmkrebs
ATE244008T1 (de) Verwendung von makroliden zur behandlung von akuten lungenverletzungen
ATE428444T1 (de) Zusammensetzungen zur vorbeugung und zur behandlung digestiver erkrankungen
ATE310521T1 (de) Praziquantel zusammensetzungen zur behandlung von krankheiten verursacht durch kokzidien
BR9809959A (pt) Mistura fungicida, e, processo para controlar fungos nocivos
ATE400259T1 (de) Verwendung von colipase-lipase-hemmern bei der herstellung einer pharmazeutischen zusammensetzung zur prävention von adipositas
ATE271384T1 (de) Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition